Shabnam Sani

Shabnam Sani currently serves as the Director of Clinical Pharmacology at Novo Nordisk since October 2023. Previously, Shabnam held the position of Associate Director, Clinical Pharmacology at Mersana Therapeutics from March 2022 to August 2023, focusing on monoclonal antibodies and study reports. Prior experience includes roles as Senior Manager, Clinical Pharmacology at Deciphera Pharmaceuticals and Senior Clinical Pharmacologist at Akebia Therapeutics, with responsibilities involving study reports and Investigational New Drug Applications (IND). Additionally, Shabnam worked as an Associate Professor and Assistant Professor at Western New England University from July 2010 to May 2019, specializing in study reports and pharmacokinetics. Shabnam holds an Executive Master in Pharmacometrics from the University of Maryland School of Pharmacy and a PhD in Pharmaceutical Sciences from the Massachusetts College of Pharmacy and Health Sciences.